UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity

Cancer chemotherapy and pharmacology, 1986-01, Vol.16 (2), p.153-155

1986

Volltextzugriff (PDF)

A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption—Part I: Gastrointestinal pH

The AAPS journal, 2016-09, Vol.18 (5), p.1309-1321

2016

Volltextzugriff (PDF)

Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug

Pharmaceutical research, 2016-07, Vol.33 (7), p.1782-1794

2016

Volltextzugriff (PDF)

Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b

Drugs (New York, N.Y.), 2010, Vol.70 (2), p.147

Foster, Graham R

2010

Volltextzugriff (PDF)

A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption—Part II: Gastrointestinal Transit Time

The AAPS journal, 2016-09, Vol.18 (5), p.1322-1333

2016

Volltextzugriff (PDF)

Levobupivacaine : A review of its pharmacology and use as a local anaesthetic

Drugs (New York, N.Y.), 2000-03, Vol.59 (3), p.551-579

2000

Volltextzugriff (PDF)

Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies

The AAPS journal, 2017-07, Vol.19 (4), p.1136-1147

2017

Volltextzugriff (PDF)

A Pharmacokinetic and Pharmacodynamic Study of Oral Oxycodone in a Human Experimental Pain Model of Hyperalgesia

Clinical pharmacokinetics, 2010-12, Vol.49 (12), p.817-827

2010

Volltextzugriff (PDF)

Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study

Investigational new drugs, 2015-08, Vol.33 (4), p.963-968

2015

Volltextzugriff (PDF)

Conventional and Dense Gas Techniques for the Production of Liposomes: A Review

AAPS PharmSciTech, 2008, Vol.9 (3), p.798-809, Article 798

2008

Volltextzugriff (PDF)

Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement

Clinical pharmacokinetics, 2015-07, Vol.54 (7), p.783-795

2015

Volltextzugriff (PDF)

Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice

Cancer chemotherapy and pharmacology, 2019-11, Vol.84 (5), p.1073-1087

2019

Volltextzugriff (PDF)

Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrations

Journal of pharmacokinetics and pharmacodynamics, 2017-06, Vol.44 (3), p.233-244

2017

Volltextzugriff (PDF)

RGS14 modulates locomotor behavior and ERK signaling induced by environmental novelty and cocaine within discrete limbic structures

Psychopharmacology, 2021-10, Vol.238 (10), p.2755-2773

2021

Volltextzugriff (PDF)

Pregabalin: in the treatment of postherpetic neuralgia

Drugs (New York, N.Y.), 2005, Vol.65 (1), p.111-118

2005

Volltextzugriff (PDF)

Olanzapine: An updated review of its use in the management of schizophrenia

Drugs (New York, N.Y.), 2001, Vol.61 (1), p.111-161

2001

Volltextzugriff (PDF)

Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response Analysis

The AAPS journal, 2020-01, Vol.22 (2), p.32, Article 32

2020

Volltextzugriff (PDF)

Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method

Drugs in R&D, 2017-03, Vol.17 (1), p.189-198

2017

Volltextzugriff (PDF)

Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers

European journal of drug metabolism and pharmacokinetics, 2019-04, Vol.44 (2), p.201-215

2019

Volltextzugriff (PDF)

Tacrolimus : A further update of its pharmacology and therapeutic use in the management of organ transplantation

Drugs (New York, N.Y.), 2000-02, Vol.59 (2), p.323-389

2000

Volltextzugriff (PDF)

Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)

Investigational new drugs, 2021-08, Vol.39 (4), p.1072-1080

2021

Volltextzugriff (PDF)

Population in vitro–in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole

Journal of pharmacokinetics and pharmacodynamics, 2018-04, Vol.45 (2), p.181-197

2018

Volltextzugriff (PDF)

CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualisation in H. pylori eradication

European journal of clinical pharmacology, 2011-03, Vol.67 (3), p.261-266

2011

Volltextzugriff (PDF)

Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat : role of CRF receptor subtypes

Psychopharmacologia, 2006-05, Vol.186 (1), p.122-132

2006

Volltextzugriff (PDF)

Cardiac gene expression data and in silico analysis provide novel insights into human and mouse taste receptor gene regulation

Naunyn-Schmiedeberg's archives of pharmacology, 2015-10, Vol.388 (10), p.1009-1027

2015

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Online Journals Complete

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(104)

Sprache

Englisch
(104)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity

A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption—Part I: Gastrointestinal pH

Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug

Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b

A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption—Part II: Gastrointestinal Transit Time

Levobupivacaine : A review of its pharmacology and use as a local anaesthetic

Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies

A Pharmacokinetic and Pharmacodynamic Study of Oral Oxycodone in a Human Experimental Pain Model of Hyperalgesia

Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study

Conventional and Dense Gas Techniques for the Production of Liposomes: A Review

Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement

Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice

Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrations

RGS14 modulates locomotor behavior and ERK signaling induced by environmental novelty and cocaine within discrete limbic structures

Pregabalin: in the treatment of postherpetic neuralgia

Olanzapine: An updated review of its use in the management of schizophrenia

Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response Analysis

Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method

Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers

Tacrolimus : A further update of its pharmacology and therapeutic use in the management of organ transplantation

Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance)

Population in vitro–in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole

CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualisation in H. pylori eradication

Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat : role of CRF receptor subtypes

Cardiac gene expression data and in silico analysis provide novel insights into human and mouse taste receptor gene regulation

Aktive Filter

Suchergebnisse filtern